Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing protein found on the surface of many solid tumor cells. We are developing a pipeline of novel cancer treatments leveraging our Click-to-Release technology in a range of therapeutic modalities, including ADCs and targeted radionuclide therapies.
We are headquartered in the Netherlands with operations in the U.S. For more information, visit us at www.tagworkspharma.com.
Company Details
- Employees
- 42
- Founded
- -
- Address
- Nijmegen, Gelderland 6525 Ga , Nl
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.tagworkspharma.com
- HQ
- Nijmegen, gelderland
Tagworks Pharmaceuticals Questions
Tagworks Pharmaceuticals's website is http://www.tagworkspharma.com
Tagworks Pharmaceuticals's LinkedIn profile is https://nl.linkedin.com/company/tagworks-pharmaceuticals
Tagworks Pharmaceuticals has
42 employees.
View email and phone details for 42
employees at Tagworks Pharmaceuticals.
Tagworks Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Tagworks Pharmaceuticals's top competitors are
Adc Therapeutics,
Genmab,
Kynexis,
Byondis,
Symeres,
Kailera Therapeutics,
Vectory,
Regenxbio,
Ardena,
Synaffix.
Tagworks Pharmaceuticals's categories are Pharmaceutical Manufacturing
Tagworks Pharmaceuticals's founding year is 2011
